Enanta Pharmaceuticals (ENTA) Cash & Equivalents (QoQ) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.70% |
| Dec 31, 2025 | 15.91% |
| Sep 30, 2025 | -27.93% |
| Jun 30, 2025 | -25.58% |
| Mar 31, 2025 | -28.61% |
| Dec 31, 2024 | 126.54% |
| Sep 30, 2024 | 4.08% |
| Jun 30, 2024 | -43.70% |
| Mar 31, 2024 | 59.12% |
| Dec 31, 2023 | -53.23% |
| Sep 30, 2023 | -10.29% |
| Jun 30, 2023 | 30.06% |
| Mar 31, 2023 | 73.31% |
| Dec 31, 2022 | -4.03% |
| Sep 30, 2022 | 55.09% |
| Jun 30, 2022 | -30.79% |
| Mar 31, 2022 | -58.63% |
| Dec 31, 2021 | 73.18% |
| Sep 30, 2021 | 1,143.34% |
| Jun 30, 2021 | -94.03% |
| Mar 31, 2021 | 39.99% |
| Dec 31, 2020 | -36.77% |
| Sep 30, 2020 | -12.74% |
| Jun 30, 2020 | 34.33% |
| Mar 31, 2020 | 169.75% |
| Dec 31, 2019 | -46.21% |
| Sep 30, 2019 | -45.62% |
| Jun 30, 2019 | -11.15% |
| Mar 31, 2019 | 42.58% |
| Dec 31, 2018 | 16.37% |
| Sep 30, 2018 | 50.44% |
| Jun 30, 2018 | -36.53% |
| Mar 31, 2018 | -1.66% |
| Dec 31, 2017 | 3.62% |
| Sep 30, 2017 | 195.00% |
| Jun 30, 2017 | 15.89% |
| Mar 31, 2017 | -6.82% |
| Dec 31, 2016 | 24.38% |
| Sep 30, 2016 | -33.13% |
| Jun 30, 2016 | -56.02% |
| Mar 31, 2016 | 21.90% |
| Dec 31, 2015 | 112.80% |
| Sep 30, 2015 | 9.48% |
| Jun 30, 2015 | -22.94% |
| Mar 31, 2015 | -24.55% |
| Dec 31, 2014 | 11.18% |
| Sep 30, 2014 | 16.40% |
| Jun 30, 2014 | 45.70% |
| Mar 31, 2014 | 308.97% |
| Dec 31, 2013 | -50.04% |
| Sep 30, 2013 | -53.07% |
| Jun 30, 2013 | -74.65% |
| Mar 31, 2013 | 259.12% |
| Dec 31, 2012 | 97.27% |
| Sep 30, 2012 | 165.36% |
| Jun 30, 2012 | -80.87% |